ArticleThe Journal of clinical endocrinology and metabolism2021

Role of A Novel Angiogenesis FKBPL-CD44 Pathway in Preeclampsia Risk Stratification and Mesenchymal Stem Cell Treatment.

Naomi Todd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.